PATENT CLAIM ANALYSIS

Application Number: 15906873
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "093210"]

Abstract:
The invention includes compositions and methods related to multimodal therapies, e.g., for treating a cancer. A multimodal therapy described herein provides and/or administers a plurality of agents that function in a coordinated manner to provide a therapeutic benefit to a subject in need thereof, e.g., a subject having a cancer.

Claim (Index 24):
A method of stimulating a T cell, comprising contacting the T cell with the enucleated erythroid cell of  claim 1 , thereby stimulating the T cell.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 88.0
- Lexical Diversity: 1.4359
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15716141', '15783921', '15824877', '15473421', '14738414']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.748455668308944
- 35 USC 102 Novelty (BERT): 0.5940433192159827
- Combined Prediction Score: 0.733014433399648
- Mean Citation Score: 392.99089
- Max Citation Score: 539.55566
- Similarity Product: 460.4348627856994

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test